1 Introduction to Research & Analysis Reports |
1.1 Isoxsuprine Market Definition |
1.2 Market Segments |
| 1.2.1 Segment by Type |
| 1.2.2 Segment by Application |
1.3 China Isoxsuprine Market Overview |
1.4 Methodology & Sources of Information |
| 1.4.1 Research Methodology |
| 1.4.2 Research Process |
| 1.4.3 Base Year |
2 China Isoxsuprine Overall Market Size |
2.1 China Isoxsuprine Market Size: 2021 VS 2027 |
2.2 China Isoxsuprine Revenue, Prospects & Forecasts: 2016-2027 |
2.3 China Isoxsuprine Sales: 2016-2027 |
3 Company Landscape |
3.1 Top Isoxsuprine Players in China Market |
3.2 Top China Isoxsuprine Companies Ranked by Revenue |
3.3 China Isoxsuprine Revenue by Companies |
3.4 China Isoxsuprine Sales by Companies |
3.5 China Isoxsuprine Price by Manufacturer (2016-2021) |
3.6 Top 3 and Top 5 Isoxsuprine Companies in China Market, by Revenue in 2020 |
3.7 Manufacturers Isoxsuprine Product Type |
3.8 Tier 1, Tier 2 and Tier 3 Isoxsuprine Players in China Market |
| 3.8.1 List of Tier 1 Isoxsuprine Companies in China |
| 3.8.2 List of Tier 2 and Tier 3 Isoxsuprine Companies in China |
4 Sights by Type |
4.1 Overview |
| 4.1.1 By Type - China Isoxsuprine Market Size Markets, 2021 & 2027 |
| 4.1.2 Use in Humans |
| 4.1.3 Use in Animals |
4.2 By Type - China Isoxsuprine Revenue & Forecasts |
| 4.2.1 By Type - China Isoxsuprine Revenue, 2016-2021 |
| 轉自:http://www.5269660.cn/3/00/China-Isoxsuprine-Market-Research-and-Trends-Report-2021-2027.html |
| 4.2.2 By Type - China Isoxsuprine Revenue, 2022-2027 |
| 4.2.3 By Type - China Isoxsuprine Revenue Market Share, 2016-2027 |
4.3 By Type - China Isoxsuprine Sales & Forecasts |
| 4.3.1 By Type - China Isoxsuprine Sales, 2016-2021 |
| 4.3.2 By Type - China Isoxsuprine Sales, 2022-2027 |
| 4.3.3 By Type - China Isoxsuprine Sales Market Share, 2016-2027 |
4.4 By Type - China Isoxsuprine Price (Manufacturers Selling Prices), 2016-2027 |
5 Sights by Application |
5.1 Overview |
| 5.1.1 By Application - China Isoxsuprine Market Size, 2021 & 2027 |
| 5.1.2 Peripheral Vasodilator |
| 5.1.3 β-Sympathomimetic Agent |
5.2 By Application - China Isoxsuprine Revenue & Forecasts |
| 5.2.1 By Application - China Isoxsuprine Revenue, 2016-2021 |
| 5.2.2 By Application - China Isoxsuprine Revenue, 2022-2027 |
| 5.2.3 By Application - China Isoxsuprine Revenue Market Share, 2016-2027 |
5.3 By Application - China Isoxsuprine Sales & Forecasts |
| 5.3.1 By Application - China Isoxsuprine Sales, 2016-2021 |
| 5.3.2 By Application - China Isoxsuprine Sales, 2022-2027 |
| 5.3.3 By Application - China Isoxsuprine Sales Market Share, 2016-2027 |
5.4 By Application - China Isoxsuprine Price (Manufacturers Selling Prices), 2016-2027 |
6 Manufacturers & Brands Profiles |
6.1 Pharco |
| 6.1.1 Pharco Corporation Information |
| 6.1.2 Pharco Overview |
| 6.1.3 Pharco Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.1.4 Pharco Isoxsuprine Product Description |
| 6.1.5 Pharco Recent Developments |
6.2 Invision Pharma |
| 6.2.1 Invision Pharma Corporation Information |
| 6.2.2 Invision Pharma Overview |
| 6.2.3 Invision Pharma Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.2.4 Invision Pharma Isoxsuprine Product Description |
| 6.2.5 Invision Pharma Recent Developments |
6.3 Zenon Healthcare |
| 6.3.1 Zenon Healthcare Corporation Information |
| 6.3.2 Zenon Healthcare Overview |
| 6.3.3 Zenon Healthcare Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.3.4 Zenon Healthcare Isoxsuprine Product Description |
| 6.3.5 Zenon Healthcare Recent Developments |
6.4 Systemic |
| 6.4.1 Systemic Corporation Information |
| 6.4.2 Systemic Overview |
| 6.4.3 Systemic Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.4.4 Systemic Isoxsuprine Product Description |
| 6.4.5 Systemic Recent Developments |
6.5 Wockhardt |
| 6.5.1 Wockhardt Corporation Information |
| 6.5.2 Wockhardt Overview |
| 6.5.3 Wockhardt Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.5.4 Wockhardt Isoxsuprine Product Description |
| 6.5.5 Wockhardt Recent Developments |
6.6 Solvay Pharma |
| 6.6.1 Solvay Pharma Corporation Information |
| 6.6.2 Solvay Pharma Overview |
| 6.6.3 Solvay Pharma Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.6.4 Solvay Pharma Isoxsuprine Product Description |
| 6.6.5 Solvay Pharma Recent Developments |
6.7 Glenmark |
| 6.7.1 Glenmark Corporation Information |
| 6.7.2 Glenmark Overview |
| 6.7.3 Glenmark Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.7.4 Glenmark Isoxsuprine Product Description |
| 6.7.5 Glenmark Recent Developments |
| 2021-2027年中國異克蘇林市場研究與趨勢報告 |
6.8 Bristol-Myers Squibb |
| 6.8.1 Bristol-Myers Squibb Corporation Information |
| 6.8.2 Bristol-Myers Squibb Overview |
| 6.8.3 Bristol-Myers Squibb Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.8.4 Bristol-Myers Squibb Isoxsuprine Product Description |
| 6.8.5 Bristol-Myers Squibb Recent Developments |
6.9 Merck Sharp and Dohme |
| 6.9.1 Merck Sharp and Dohme Corporation Information |
| 6.9.2 Merck Sharp and Dohme Overview |
| 6.9.3 Merck Sharp and Dohme Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.9.4 Merck Sharp and Dohme Isoxsuprine Product Description |
| 6.9.5 Merck Sharp and Dohme Recent Developments |
6.10 Amriya |
| 6.10.1 Amriya Corporation Information |
| 6.10.2 Amriya Overview |
| 6.10.3 Amriya Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.10.4 Amriya Isoxsuprine Product Description |
| 6.10.5 Amriya Recent Developments |
6.11 Pfizer |
| 6.11.1 Pfizer Corporation Information |
| 6.11.2 Pfizer Overview |
| 6.11.3 Pfizer Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.11.4 Pfizer Isoxsuprine Product Description |
| 6.11.5 Pfizer Recent Developments |
6.12 Winston Pharma |
| 6.12.1 Winston Pharma Corporation Information |
| 6.12.2 Winston Pharma Overview |
| 6.12.3 Winston Pharma Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.12.4 Winston Pharma Isoxsuprine Product Description |
| 6.12.5 Winston Pharma Recent Developments |
6.13 Johnson and Johnson |
| 6.13.1 Johnson and Johnson Corporation Information |
| 6.13.2 Johnson and Johnson Overview |
| 6.13.3 Johnson and Johnson Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.13.4 Johnson and Johnson Isoxsuprine Product Description |
| 6.13.5 Johnson and Johnson Recent Developments |
6.14 Aspen Pharmacare |
| 6.14.1 Aspen Pharmacare Corporation Information |
| 6.14.2 Aspen Pharmacare Overview |
| 6.14.3 Aspen Pharmacare Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.14.4 Aspen Pharmacare Isoxsuprine Product Description |
| 6.14.5 Aspen Pharmacare Recent Developments |
6.15 Abbott |
| 6.15.1 Abbott Corporation Information |
| 6.15.2 Abbott Overview |
| 6.15.3 Abbott Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.15.4 Abbott Isoxsuprine Product Description |
| 6.15.5 Abbott Recent Developments |
6.16 Drugmaker's Laboratoires |
| 6.16.1 Drugmaker's Laboratoires Corporation Information |
| 6.16.2 Drugmaker's Laboratoires Overview |
| 6.16.3 Drugmaker's Laboratoires Isoxsuprine Sales and Revenue in China Market (2016-2021) |
| 6.16.4 Drugmaker's Laboratoires Isoxsuprine Product Description |
| 6.16.5 Drugmaker's Laboratoires Recent Developments |
7 China Isoxsuprine Production Capacity, Analysis |
7.1 China Isoxsuprine Production Capacity, 2016-2027 |
7.2 Isoxsuprine Production Capacity of Key Manufacturers in China Market |
8 Key Market Trends, Opportunity, Drivers and Restraints |
8.1 Market Opportunities & Trends |
8.2 Market Drivers |
8.3 Market Restraints |
9 Isoxsuprine Supply Chain Analysis |
9.1 Isoxsuprine Industry Value Chain |
9.2 Isoxsuprine Upstream Market |
| 2021-2027年中國異克蘇林市場研究與趨勢報告 |
9.3 Isoxsuprine Downstream and Clients |
9.4 Marketing Channels Analysis |
| 9.4.1 Marketing Channels |
| 9.4.2 Isoxsuprine Distributors and Sales Agents in China Market |
10 Conclusion |
11 Appendix |
11.1 Note |
11.2 Examples of Clients |
11.3 Author Details |
11.4 Disclaimer |
| List of Tables |
| Table 1. Key Players of Isoxsuprine in China Market |
| Table 2. Top Isoxsuprine Players in China Market, Ranking by Revenue (2019) |
| Table 3. China Isoxsuprine Revenue by Companies, (US$, Mn), 2016-2021 |
| Table 4. China Isoxsuprine Revenue Share by Companies, 2016-2021 |
| Table 5. China Isoxsuprine Sales by Companies, (K Units), 2016-2021 |
| Table 6. China Isoxsuprine Sales Share by Companies, 2016-2021 |
| Table 7. Key Manufacturers Isoxsuprine Price (2016-2021) & (US$/Unit) |
| Table 8. Manufacturers Isoxsuprine Product Type |
| Table 9. List of Tier 1 Isoxsuprine Companies, Revenue (US$, Mn) in 2020 and Market Share |
| Table 10. List of Tier 2 and Tier 3 Isoxsuprine Companies, Revenue (US$, Mn) in 2020 and Market Share |
| Table 11. Major Manufacturers of Use in Humans |
| Table 12. Major Manufacturers of Use in Animals |
| Table 13. By Type – China Isoxsuprine Revenue, (US$, Mn), 2021 & 2027 |
| Table 14. By Type - China Isoxsuprine Revenue (US$, Mn), 2016-2021 |
| Table 15. By Type - China Isoxsuprine Revenue (US$, Mn), 2022-2027 |
| Table 16. By Type - China Isoxsuprine Sales (K Units), 2016-2021 |
| Table 17. By Type - China Isoxsuprine Sales (K Units), 2022-2027 |
| Table 18. By Application – China Isoxsuprine Revenue, (US$, Mn), 2021 VS 2027 |
| Table 19. By Application - China Isoxsuprine Revenue (US$, Mn), 2016-2021 |
| Table 20. By Application - China Isoxsuprine Revenue (US$, Mn), 2022-2027 |
| Table 21. By Application - China Isoxsuprine Sales (K Units), 2016-2021 |
| Table 22. By Application - China Isoxsuprine Sales (K Units), 2022-2027 |
| Table 23. Pharco Corporation Information |
| Table 24. Pharco Description and Major Businesses |
| Table 25. Pharco Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 26. Pharco Isoxsuprine Product |
| Table 27. Pharco Recent Developments |
| Table 28. Invision Pharma Corporation Information |
| Table 29. Invision Pharma Description and Major Businesses |
| Table 30. Invision Pharma Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 31. Invision Pharma Isoxsuprine Product |
| Table 32. Invision Pharma Recent Developments |
| Table 33. Zenon Healthcare Corporation Information |
| Table 34. Zenon Healthcare Description and Major Businesses |
| Table 35. Zenon Healthcare Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 36. Zenon Healthcare Isoxsuprine Product |
| Table 37. Zenon Healthcare Recent Developments |
| Table 38. Systemic Corporation Information |
| Table 39. Systemic Description and Major Businesses |
| Table 40. Systemic Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 41. Systemic Isoxsuprine Product |
| Table 42. Systemic Recent Developments |
| Table 43. Wockhardt Corporation Information |
| Table 44. Wockhardt Description and Major Businesses |
| Table 45. Wockhardt Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 46. Wockhardt Isoxsuprine Product |
| Table 47. Wockhardt Recent Developments |
| Table 48. Solvay Pharma Corporation Information |
| Table 49. Solvay Pharma Description and Major Businesses |
| Table 50. Solvay Pharma Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 51. Solvay Pharma Isoxsuprine Product |
| Table 52. Solvay Pharma Recent Developments |
| Table 53. Glenmark Corporation Information |
| 2021-2027 Nian Zhong Guo Yi Ke Su Lin Shi Chang YanJiu Yu Qu Shi Bao Gao |
| Table 54. Glenmark Description and Major Businesses |
| Table 55. Glenmark Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 56. Glenmark Isoxsuprine Product |
| Table 57. Glenmark Recent Developments |
| Table 58. Bristol-Myers Squibb Corporation Information |
| Table 59. Bristol-Myers Squibb Description and Major Businesses |
| Table 60. Bristol-Myers Squibb Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 61. Bristol-Myers Squibb Isoxsuprine Product |
| Table 62. Bristol-Myers Squibb Recent Developments |
| Table 63. Merck Sharp and Dohme Corporation Information |
| Table 64. Merck Sharp and Dohme Description and Major Businesses |
| Table 65. Merck Sharp and Dohme Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 66. Merck Sharp and Dohme Isoxsuprine Product |
| Table 67. Merck Sharp and Dohme Recent Developments |
| Table 68. Amriya Corporation Information |
| Table 69. Amriya Description and Major Businesses |
| Table 70. Amriya Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 71. Amriya Isoxsuprine Product |
| Table 72. Amriya Recent Developments |
| Table 73. Pfizer Corporation Information |
| Table 74. Pfizer Description and Major Businesses |
| Table 75. Pfizer Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 76. Pfizer Isoxsuprine Product |
| Table 77. Pfizer Recent Developments |
| Table 78. Winston Pharma Corporation Information |
| Table 79. Winston Pharma Description and Major Businesses |
| Table 80. Winston Pharma Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 81. Winston Pharma Isoxsuprine Product |
| Table 82. Winston Pharma Recent Developments |
| Table 83. Johnson and Johnson Corporation Information |
| Table 84. Johnson and Johnson Description and Major Businesses |
| Table 85. Johnson and Johnson Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 86. Johnson and Johnson Isoxsuprine Product |
| Table 87. Johnson and Johnson Recent Developments |
| Table 88. Aspen Pharmacare Corporation Information |
| Table 89. Aspen Pharmacare Description and Major Businesses |
| Table 90. Aspen Pharmacare Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 91. Aspen Pharmacare Isoxsuprine Product |
| Table 92. Aspen Pharmacare Recent Developments |
| Table 93. Abbott Corporation Information |
| Table 94. Abbott Description and Major Businesses |
| Table 95. Abbott Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 96. Abbott Isoxsuprine Product |
| Table 97. Abbott Recent Developments |
| Table 98. Drugmaker's Laboratoires Corporation Information |
| Table 99. Drugmaker's Laboratoires Description and Major Businesses |
| Table 100. Drugmaker's Laboratoires Isoxsuprine Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) |
| Table 101. Drugmaker's Laboratoires Isoxsuprine Product |
| Table 102. Drugmaker's Laboratoires Recent Developments |
| Table 103. Isoxsuprine Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units) |
| Table 104. China Isoxsuprine Capacity Market Share of Key Manufacturers, 2019-2021 |
| Table 105. Isoxsuprine Market Opportunities & Trends in China Market |
| Table 106. Isoxsuprine Market Drivers in China Market |
| Table 107. Isoxsuprine Market Restraints in China Market |
| Table 108. Isoxsuprine Raw Materials |
| Table 109. Isoxsuprine Raw Materials Suppliers in China Market |
| Table 110. Typical Isoxsuprine Downstream |
| Table 111. Isoxsuprine Downstream Clients in China Market |
| Table 112. Isoxsuprine Distributors and Sales Agents in China Market |
| List of Figures |
| Figure 1. Isoxsuprine Product Picture |
| Figure 2. Isoxsuprine Segment by Type |
| Figure 3. Isoxsuprine Segment by Application |
| Figure 4. China Isoxsuprine Market Overview: 2020 |
| 中國イソクスプリンの市場調査と動向レポート2021-2027 |
| Figure 5. China Isoxsuprine Market Size: 2021 VS 2027 (US$, Mn) |
| Figure 6. China Isoxsuprine Revenue, 2016-2027 (US$, Mn) |
| Figure 7. Isoxsuprine Sales in China Market: 2016-2027 (K Units) |
| Figure 8. The Top 3 and 5 Players Market Share by Isoxsuprine Revenue in 2020 |
| Figure 9. Use in Humans Product Picture |
| Figure 10. Use in Animals Product Picture |
| Figure 11. By Type - China Isoxsuprine Sales Market Share, 2016-2027 |
| Figure 12. By Type - China Isoxsuprine Revenue Market Share, 2016-2027 |
| Figure 13. By Type - China Isoxsuprine Price (US$/Unit), 2016-2027 |
| Figure 14. Peripheral Vasodilator |
| Figure 15. β-Sympathomimetic Agent |
| Figure 16. By Application - China Isoxsuprine Sales Market Share, 2016-2027 |
| Figure 17. By Application - China Isoxsuprine Revenue Market Share, 2016-2027 |
| Figure 18. By Application - China Isoxsuprine Price (US$/Unit), 2016-2027 |
| Figure 19. Pharco Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 20. Invision Pharma Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 21. Zenon Healthcare Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 22. Systemic Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 23. Wockhardt Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 24. Solvay Pharma Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 25. Glenmark Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 26. Bristol-Myers Squibb Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 27. Merck Sharp and Dohme Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 28. Amriya Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 29. Pfizer Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 30. Winston Pharma Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 31. Johnson and Johnson Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 32. Aspen Pharmacare Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 33. Abbott Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 34. Drugmaker's Laboratoires Isoxsuprine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) |
| Figure 35. China Isoxsuprine Production Capacity (K Units), 2016-2027 |
| Figure 36. Isoxsuprine Industry Value Chain |
| Figure 37. Marketing Channels |
http://www.5269660.cn/3/00/China-Isoxsuprine-Market-Research-and-Trends-Report-2021-2027.html
略……

如需購買《China Isoxsuprine Market Research and Trends Report 2021-2027》,編號:3180003
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”


京公網安備 11010802027365號